Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mai A. Alim A. Sattar Ahmad"'
Publikováno v:
Journal of Pharmaceutical Research International. :246-256
Dyslipidemia is usually observed in both types of diabetes and, particularly, “atherogenic dyslipidemic triad” is strongly linked to a higher risk of adverse cardiovascular outcome. On the other hand, bone morphogenetic proteins (BMP) are a group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51a907b9d3c344b9a7e29f0534fd3e08
https://doi.org/10.9734/jpri/2021/v33i51a33490
https://doi.org/10.9734/jpri/2021/v33i51a33490
Publikováno v:
Journal of Pharmaceutical Research International. :127-134
Aim: To determine the potential hepatoprotective effect of Agmatine (AGM) on NAFLD-induced by Type 2 diabetes mellitus (T2DM) in rats. Study design: Forty male Wistar rats weighing from (200 -250 g) were distributed at random into five groups (8 rats
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4961ffa2909dc692f73ce502bd8d3eac
https://doi.org/10.9734/jpri/2021/v33i31a31671
https://doi.org/10.9734/jpri/2021/v33i31a31671
Publikováno v:
Journal of Pharmaceutical Research International. :152-165
Background: Our recent past studies accomplished the target to investigate the anti-inflammatory effect as well as toxicological profile of Commiphora opobalsamum (CO), with almost identical potency in comparison to the contemporary anti-inflammatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e517e1be65bb4a19de1d6ad0103ef53f
https://doi.org/10.9734/jpri/2021/v33i29a31574
https://doi.org/10.9734/jpri/2021/v33i29a31574
Publikováno v:
Journal of Pharmaceutical Research International. :31-42
Aim: To study acute and chronic toxicity profile of Commiphora opobalsamum (CO) in rats. Methods: Acute oral lethal effect and single oral dose toxicity of CO was determined in rats by comparison with standard control. In contrast repeated dose oral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6628944f5827f1e5ec9608cfd4e523f3
https://doi.org/10.9734/jpri/2021/v33i19a31324
https://doi.org/10.9734/jpri/2021/v33i19a31324
Publikováno v:
Journal of Pharmaceutical Research International. 22:1-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a90be9fba18ac4260317f258eec2c9e
https://doi.org/10.9734/jpri/2018/40943
https://doi.org/10.9734/jpri/2018/40943